Details for Patent: 12,138,278
Which drugs does patent 12,138,278 protect, and when does it expire?
Patent 12,138,278 protects CABTREO and is included in one NDA.
This patent has twelve patent family members in ten countries.
Summary for Patent: 12,138,278
| Title: | Topical compositions |
| Abstract: | The disclosure provides a topical gel formulation comprising 1-1.5 wt. % clindamycin phosphate, 2.5-3.5 wt. % benzoyl peroxide, and 0.1-0.2 wt. % adapalene, in combination with a gelling agent, a polyhydric alcohol, and water, useful in treating inflammatory skin conditions, including acne, together with methods of making and using the same. |
| Inventor(s): | Varsha Bhatt, Radhakrishnan Pillai, Arturo Angel |
| Assignee: | Bausch Health Ireland Ltd |
| Application Number: | US18/639,630 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 12,138,278 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; |
Drugs Protected by US Patent 12,138,278
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | CABTREO | adapalene; benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 216632-001 | Oct 20, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,138,278
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2020322173 | ⤷ Start Trial | |||
| Canada | 3149296 | ⤷ Start Trial | |||
| China | 114126582 | ⤷ Start Trial | |||
| China | 119837892 | ⤷ Start Trial | |||
| Colombia | 2022002253 | ⤷ Start Trial | |||
| European Patent Office | 4007566 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
